Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.

Join the discussion on Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) sentiment. Share your thoughts on CUPR whether it feels bullish, bearish, or somewhere in between. Please keep the discussion civil and relevant.